The reverse split is a technical adjustment to maintain Nasdaq listing compliance. Monitor the stock price post-split for ability to sustain above $1.00 bid price. No fundamental change in business outlook; watch for potential future financing or operational updates.
CRIS drugs
CRIS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Jul 2 $0.3466entry
- T+1 · due 4mo ago Pending
- T+5 · 4mo ago +1331.04%α +1330.11% · $4.96
- T+20 · 4mo ago +1331.04%α +1331.46% · $4.96
- T+60 · due 7w ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Curis Inc. filed a certificate of amendment to effect a 1-for-20 reverse stock split of its common stock, effective July 2, 2026. Trading on a split-adjusted basis begins July 6, 2026, under the same ticker CRIS. The reverse split is a routine capital structure adjustment, likely to maintain Nasdaq listing compliance given the company's $16M market cap.
Key Facts
- 1-for-20 reverse stock split effective 5:00 p.m. ET on July 2, 2026
- Trading on split-adjusted basis begins at market open on July 6, 2026
- Ticker symbol CRIS unchanged; new CUSIP 231269408
- No fractional shares issued; fractional interests rounded up to nearest whole share
- Par value remains $0.01 per share; authorized share count unchanged at 567,514,300 shares of common stock
- Outstanding warrants, RSUs, stock options, and equity incentive plan shares adjusted proportionally
Financial Impact
No direct financial impact; reverse split reduces outstanding share count by 20x but does not change total equity or authorized shares
Risk Factors
- Stock may fail to maintain minimum bid price post-split, leading to delisting risk
- Reverse split often signals financial distress; further dilution from equity offerings possible
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001108205-26-000078 |
| Document: crisex31-certificateofamen.htm | 0001108205-26-000078 |
| Document: 0001108205-26-000078-index-headers.html | 0001108205-26-000078 |
| Document: 0001108205-26-000078-index.html | 0001108205-26-000078 |
| Document: 0001108205-26-000078.txt | 0001108205-26-000078 |
Track record
18 reports on CRIS
7 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +82.45% at T+60 after the May 22, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.4200 Now $0.4400 +4.76% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.6000 Now $0.4400 −26.67% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5010 Now $0.4400 −12.18% settles Nov 17
- Nov 13, 20263d ago S-3 Bearish 7/10 Entry $0.6000 Now $0.4400 +26.67% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $0.4450 Now $0.4400 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $0.4450 to $0.4358 Now $0.4400 +1.12% ▲ +2.07% +0.16% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $0.6530 to $0.5915 Now $0.4400 −32.62% ▼ −9.42% −10.74% vs SPY
- Nov 6, 202610d ago 8-K Bearish 7/10 Entry $0.6976 to $0.6530 Now $0.4400 +36.93% ▲ +6.39% +6.03% vs SPY
- Nov 2, 202614d ago DEF 14A Neutral 4/10 Entry $0.6610 to $0.7139 Now $0.4400 −33.43% ▲ +8.00% +7.70% vs SPY
- Oct 19, 202628d ago 8-K Bearish 6/10 Entry $0.3996 to $0.3920 Now $0.4400 −10.11% ▲ +1.90% +2.43% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers